From what 5 stock analysts predict, the share price for Surgery Partners Inc (SGRY) might increase by 21.47% in the next year. This is based on a 12-month average estimation for SGRY. Price targets go from $35.00 to $50.00. The majority of stock analysts believe SGRY is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
SGRY is a stock in Health Care which has been forecasted to be worth $42.60 as an average. On the higher end, the forecast price is $50.00 USD by kevin fischbeck from Bank of America Securities and on the lower end SGRY is forecasted to be $35.00 by gary taylor from TD Cowen.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
bill sutherland Benchmark Co. | Buy | $50.0 | reiterated | Jan 10, 2024 |
whit mayo Leerink Partners | Buy | $47.0 | reiterated | Jan 9, 2024 |
lisa gill J.P. Morgan | Hold | $38.0 | maintained | Dec 13, 2023 |
jason cassorla Citi | Buy | $43.0 | reiterated | Dec 7, 2023 |
gary taylor TD Cowen | Buy | $35.0 | upgraded | Nov 14, 2023 |
ann hynes Mizuho Securities | Buy | $42.0 | reiterated | Nov 7, 2023 |
ben hendrix RBC Capital | Buy | $47.0 | maintained | Nov 7, 2023 |
kevin fischbeck Bank of America Securities | Buy | $50.0 | maintained | Aug 1, 2023 |
steven valiquette Barclays | Buy | $51.0 | rated | Aug 1, 2023 |
sarah james Cantor Fitzgerald | Buy | $43.0 | initiatedcoverage | Apr 20, 2023 |
tao qiu Stifel Nicolaus | Buy | $40.0 | maintained | Mar 2, 2023 |
brian tanquilut Jefferies | Buy | $75.0 | maintained | Mar 1, 2022 |
chad vanacore Stifel Nicolaus | Hold | $12.0 | maintained | May 8, 2019 |
ana gupte SVB Securities | Buy | $25.0 | reiterated | Aug 13, 2018 |
john ransom Raymond James | Hold | None | maintained | Aug 9, 2018 |
jason gurda KeyBanc | Buy | $21.0 | reiterated | Nov 9, 2016 |
joshua raskin Nephron | Hold | $20.0 | reiterated | Aug 10, 2016 |
andrew schenker Morgan Stanley | Hold | $22.0 | reiterated | May 6, 2016 |
In 2023, SGRY generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that SGRY's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TMUS-USD
$161.76
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TXG-USD
$49.11